OraSure Technologies Given Consensus Recommendation of “Hold” by Brokerages (NASDAQ:OSUR)
OraSure Technologies (NASDAQ:OSUR) has received an average rating of “Hold” from the eight analysts that are covering the company, Stock Ratings News reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $9.70.
Shares of OraSure Technologies (NASDAQ:OSUR) traded up 1.08% on Tuesday, hitting $8.42. 34,417 shares of the company’s stock traded hands. OraSure Technologies has a 52-week low of $4.80 and a 52-week high of $9.00. The stock has a 50-day moving average of $8.12 and a 200-day moving average of $7.48. The company has a market cap of $471.4 million and a price-to-earnings ratio of 438.42.
OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.08. The company had revenue of $26.40 million for the quarter, compared to the consensus estimate of $26.21 million. During the same quarter in the previous year, the company posted ($0.10) earnings per share. The company’s revenue for the quarter was up 8.5% on a year-over-year basis. Analysts expect that OraSure Technologies will post $-0.15 EPS for the current fiscal year.
OSUR has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of OraSure Technologies from an “outperform” rating to a “neutral” rating in a research note on Tuesday, August 12th. They now have a $9.20 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of OraSure Technologies in a research note on Thursday, June 12th. They now have a $10.00 price target on the stock, up previously from $9.00. Finally, analysts at Raymond James raised their price target on shares of OraSure Technologies from $8.50 to $9.00 in a research note on Thursday, June 12th.
OraSure Technologies, Inc, is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using the Company’s oral fluid technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.